Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands

C Boersma, R Klok, J Bos, Mark Naunton, P Van Den Berg, L Dejong-Van den Berg, M Postma

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)191-196
    Number of pages6
    JournalApplied Health Economics and Health Policy
    Issue number3
    Publication statusPublished - 2005

    Cite this